New eye drops aim to soothe dry, red eyes

NCT ID NCT07007702

Completed Symptom relief Sponsor: Laboratoires Thea Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new preservative-free eye drop (Thealoz Total) in 30 adults with chronic dry eye and eye redness. Participants used the drops daily for 12 weeks. Researchers measured changes in redness and how satisfied patients felt. The goal was to see if the drops improve comfort and reduce inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: trehalose, sodium hyaluronate, and N-Acetyl Aspartyl Glutamic Acid (NAAGA) in preservative-free eye drops
What this could lead to: If successful, this could offer a new option for people with chronic dry eye to reduce redness and feel more comfortable.
What could go wrong: This is a small, early study with only 30 people and no comparison group, so results may not apply to everyone. The drops are meant to ease symptoms, not cure dry eye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE (DED)

Contacts and locations

Locations

Universitätsklinik für Klinische Pharmakologie, Allgemeines Krankenhaus Wien

Vienna, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.